Two million new people start taking the oral anticoagulant drug Coumadin (also known generically as warfarin) every year to prevent blood clots, heart attacks and stroke. Dosing of warfarin is complicated by the fact that it interacts with many commonly used medications and even with chemicals that may be present in certain foods. These interactions may enhance or reduce warfarin’s anticoagulation effect. In order to optimize the therapeutic effect without risking dangerous side effects such as bleeding, close monitoring of the degree of anti-coagulation is required by blood testing.
Correct dosing of warfarin is determined for each patient by periodically measuring blood clotting time using the prothrombin time or, as it’s commonly called, the PT test. The new Coag-Sense system offers clinicians a PT test with simplicity, performance, and reliability. The portable system is CLIA waived for physician office labs, and unlike electrochemical detection based devices, the Coag-Sense system does not rely on the concentration of blood constituents not involved in clot formation to produce results. This improves precision and reduces variability in readings often seen in other systems. The results of the Coag-Sense are comparable to gold standard WHO tilt-tube method.
The Coag-Sense meter directly measures the prothrombin time, so the time required to perform a test is the actual prothrombin time in seconds. There is no need for tables or curve-fitting algorithms— the Coag-Sense meter offers both speed and accuracy.
The Coag-Sense System is available exclusively through a network of qualified distributors, which includes QuickMedical. Contact us today and a trained product specialist will assist you in purchasing and setting up your Coag-Sense system.